Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice

Journal of Immunology

Volumn 176, Issue 3, 2006, Pages 1637-1644

  Wong, Carmen P ^a   Li, Li ^a   Frelinger, Jeffrey A ^a   Tisch, Roland ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; GLUCOSE 6 PHOSPHATASE; ISLET SPECIFIC GLUCOSE 6 PHOSPHATASE CATALYTIC SUBUNIT RELATED PROTEIN; ISLET SPECIFIC GLUCOSE 6 PHOSPHATASE CATALYTIC SUBUNIT RELATED PROTEIN[206-214]; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CELL COUNT; CELL INFILTRATION; CLONE; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GRAFT REJECTION; GRAFT SURVIVAL; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

EID: 31144440201     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.3.1637     Document Type: Article

References (42)

1. Anderson, M. S., and J. A. Bluestone. 2005. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23: 447-485.
2. Delovitch, T. L., and B. Singh. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7: 727-738.
3. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85: 291-297.
4. + T cells in NOD mice. Immunol. Rev. 204: 250-263.
5. Graser, R. T., T. P. DiLorenzo, F. Wang, G. J. Christianson, H. D. Chapman, D. C. Roopenian, S. G. Nathenson, and D. V. Serreze. 2000. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J. Immunol. 164: 3913-3918.
6. Wong, F. S., I. Visintin, L. Wen, R. A. Flavell, and C. A. Janeway, Jr. 1996. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183: 67-76.
7. Verdaguer, J., D. Schmidt, A. Amrani, B. Anderson, N. Averill, and P. Santamaria. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186: 1663-1676.
8. + T cells in the initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol. 26: 1762-1769.
9. 2-microglobulin-deficient non-obese diabetic mice. Int. Immunol. 6: 1445-1449.
10. null mice are diabetes and insulitis resistant. Diabetes 43: 505-509.
11. 2-Microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43: 500-504.
12. Hamilton-Williams, E. E., S. E. Palmer, B. Charlton, and R. M. Slattery. 2003. β cell MHC class I is a late requirement for diabetes. Proc. Natl. Acad. Sci. USA 100: 6688-6693.
13. Hanninen, A., S. Jalkanen, M. Salmi, S. Toikkanen, G. Nikolakaros, and O. Simell. 1992. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J. Clin. Invest. 90: 1901-1910.
14. Itoh, N., T. Hanafusa, A. Miyazaki, J. Miyagawa, K. Yamagata, K. Yamamoto, M. Waguri, A. Imagawa, S. Tamura, M. Inada, et al. 1993. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J. Clin. Invest. 92: 2313-2322.
15. Somoza, N., F. Vargas, C. Roura-Mir, M. Vives-Pi, M. T. Fernandez-Figueras, A. Ariza, R. Gomis, R. Bragado, M. Marti, D. Jaraquemada, et al. 1994. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor Vβ usage, and cytokine profile. J. Immunol. 153: 1360-1377.
16. Santamaria, P., R. E. Nakhleh, D. E. Sutherland, and J. J. Barbosa. 1992. Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes 41: 53-61.
17. + T cell response against one peptide/MHC complex in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 96: 9311-9316.
18. + T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 100: 8384-8388.
19. Trudeau, J. D., C. Kelly-Smith, C. B. Verchere, J. F. Elliott, J. P. Dutz, D. T. Finegood, P. Santamaria, and R. Tan. 2003. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 111: 217-223.
20. Amrani, A., J. Verdaguer, P. Serra, S. Tafuro, R. Tan, and P. Santamaria. 2000. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406: 739-742.
21. Wong, F. S., J. Karttunen, C. Dumont, L. Wen, I. Visintin, I. M. Pilip, N. Shastri, E. G. Pamer, and C. A. Janeway, Jr. 1999. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 5: 1026-1031.
22. + T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J. Immunol. 173: 6727-6734.
23. Stegall, M. D., K. J. Lafferty, I. Kam, and R. G. Gill. 1996. Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation 61: 1272-1274.
24. Okitsu, T., S. T. Bartlett, G. A. Hadley, C. B. Drachenberg, and A. C. Farney. 2001. Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice. Am. J. Transplant. 1: 138-145.
25. Prange, S., P. Zucker, A. M. Jevnikar, and B. Singh. 2001. Transplanted MHC class I-deficient nonobese diabetic mouse islets are protected from autoimmune injury in diabetic nonobese recipients. Transplantation 71: 982-985.
26. Young, H. Y., P. Zucker, R. A. Flavell, A. M. Jevnikar, and B. Singh. 2004. Characterization of the role of major histocompatibility complex in type 1 diabetes recurrence after islet transplantation. Transplantation 78: 509-515.
27. d that stimulates CD8 T cells in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 99: 5551-5556.
28. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
29. Baker, F. J., M. Lee, Y. H. Chien, and M. M. Davis. 2002. Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice. Proc. Natl. Acad. Sci. USA 99: 9374-9379.
30. Lefranc, M. P., V. Giudicelli, C. Ginestoux, J. Bodmer, W. Muller, R. Bontrop, M. Lemaitre, A. Malik, V. Barbie, and D. Chaume. 1999. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 27: 209-212.
31. Lefranc, M. P. 2001. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 29: 207-209.
32. Lefranc, M. P. 2003. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 31: 307-310.
33. Lefranc, M. P., V. Giudicelli, C. Ginestoux, N. Bosc, G. Folch, D. Guiraudou, J. Jabado-Michaloud, S. Magris, D. Scaviner, V. Thouvenin, et al. 2004. IMGT-ONTOLOGY for immunogenetics and immunoinformatics. In Silico Biol. 4: 17-29.
34. Lefranc, M. P., V. Giudicelli, Q. Kaas, E. Duprat, J. Jabado-Michaloud, D. Scaviner, C. Ginestoux, O. Clement, D. Chaume, and G. Lefranc. 2005. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 33: D593-D597.
35. Ruiz, M., V. Giudicelli, C. Ginestoux, P. Stoehr, J. Robinson, J. Bodmer, S. G. Marsh, R. Bontrop, M. Lemaitre, G. Lefranc, et al. 2000. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 28: 219-221.
36. Arden, B., S. P. Clark, D. Kabelitz, and T. W. Mak. 1995. Mouse T-cell receptor variable gene segment families. Immunogenetics 42: 501-530.
37. Martinez, N. R., P. Augstein, A. K. Moustakas, G. K. Papadopoulos, S. Gregori, L. Adorini, D. C. Jackson, and L. C. Harrison. 2003. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J. Clin. Invest. 111: 1365-1371.
38. Quinn, A., M. F. McInerney, and E. E. Sercarz. 2001. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity. J. Immunol. 167: 1748-1757.
39. Mottram, P. L., L. J. Murray-Segal, W. Han, J. Maguire, A. Stein-Oakley, and T. E. Mandel. 1998. Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies. Diabetes 47: 1399-1405.
40. Makhlouf, L., S. T. Grey, V. Dong, E. Csizmadia, M. B. Arvelo, H. Auchincloss, Jr., C. Ferran, and M. H. Sayegh. 2004. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice. Transplantation 77: 990-997.
41. Kupfer, T. M., M. L. Crawford, K. Pham, and R. G. Gill. 2005. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo. J. Immunol. 175: 2309-2316.
42. Han, B., P. Serra, A. Amrani, J. Yamanouchi, A. F. Maree, L. Edelstein-Keshet, and P. Santamaria. 2005. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat. Med. 11: 645-652.